Futures in Biotech

On the latest episode (#14, posted on 3/23/07) of Futures in Biotech, host Marc Pelletier talks with the founder and scientists from the Myelin Repair Foundation.  The MRF is pioneering a new collaborative form of research aimed at developing treatments for multiple sclerosis, which is a disease where the myelin insulation of neurons is destroyed in an intermittent and unpredictable manner.

As of March 24, there are no show notes on the website; but I will mention that although this podcast appears fairly irregularly,  it often has interviews with leading-edge scientists in the biotech field.  One of my favorite interviews was Episode 10 with Harvard neurobiologist, Dr. Carla Shatz.